Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Palladyne AI
PDYN
$285M
| $116K | ﹤0.01% |
19,011
+5,512
| +41% | +$36.5K |
|
3652
Sight Sciences
SGHT
$446M
| $115K | ﹤0.01% |
21,274
+8,236
| +63% | +$37.9K |
|
3653
Inspired Entertainment
INSE
$144M
| $112K | ﹤0.01% |
13,619
-6,854
| -33% | -$51K |
|
3654
Rimini Street
RMNI
$448M
| $112K | ﹤0.01% |
26,268
+7,635
| +41% | +$28.9K |
|
3655
Forrester Research
FORR
$232M
| $111K | ﹤0.01% |
13,211
-7,390
| -36% | -$48.3K |
|
3656
Playtika
PLTK
$847M
| $111K | ﹤0.01% |
29,774
-12,637
| -30% | -$43.7K |
|
|
WDH
3657
Waterdrop
WDH
$384M
| $110K | ﹤0.01% |
97,672
-13,564
| -12% | -$20.6K |
|
3658
Companhia Siderúrgica Nacional
SID
$1.64B
| $109K | ﹤0.01% |
118,968
-5,078
| -4% | -$6.36K |
|
3659
Orchestra BioMed
OBIO
$326M
| $107K | ﹤0.01% |
+24,689
| New | +$101K |
|
|
AUTL
3660
Autolus Therapeutics
AUTL
$562M
| $106K | ﹤0.01% |
66,447
+13,294
| +25% | +$20.9K |
|
|
BCYC
3661
Bicycle Therapeutics
BCYC
$293M
| $105K | ﹤0.01% |
24,802
+9,735
| +65% | +$44.6K |
|
3662
Innoviz Technologies
INVZ
$105M
| $105K | ﹤0.01% |
137,915
+55,000
| +66% | +$37.6K |
|
|
RSVR
3663
Reservoir Media
RSVR
$603M
| $103K | ﹤0.01% |
10,440
-2,891
| -22% | -$29.2K |
|
3664
SKYX Platforms
SKYX
$183M
| $103K | ﹤0.01% |
93,213
+58,398
| +168% | +$64.7K |
|
|
PROF
3665
Profound Medical
PROF
$249M
| $103K | ﹤0.01% |
+15,454
| New | +$104K |
|
3666
Protara Therapeutics
TARA
$230M
| $103K | ﹤0.01% |
26,856
+8,895
| +50% | +$42.3K |
|
3667
Seres Therapeutics
MCRB
$55.8M
| $102K | ﹤0.01% |
12,974
-1,573
| -11% | -$12K |
|
3668
Microbot Medical
MBOT
$101M
| $102K | ﹤0.01% |
52,201
+22,781
| +77% | +$46.4K |
|
3669
Asure Software
ASUR
$256M
| $100K | ﹤0.01% |
12,650
+1,541
| +14% | +$13.4K |
|
3670
American Resources Corp
AREC
$262M
| $99.2K | ﹤0.01% |
+46,144
| New | +$103K |
|
3671
Exagen
XGN
$177M
| $98.3K | ﹤0.01% |
+21,133
| New | +$79.6K |
|
3672
InflaRx
IFRX
$320M
| $98.2K | ﹤0.01% |
+43,851
| New | +$82.4K |
|
3673
CAMP4 Therapeutics
CAMP
$276M
| $98K | ﹤0.01% |
+22,425
| New | +$96.7K |
|
3674
Arq
ARQ
$96.5M
| $97.2K | ﹤0.01% |
38,132
+394
| +1% | +$978 |
|
|
ONCY
3675
Oncolytics Biotech
ONCY
$103M
| $96.1K | ﹤0.01% |
+101,195
| New | +$93.8K |
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.